BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17122002)

  • 1. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates.
    Pitout JD; Chow BL; Gregson DB; Laupland KB; Elsayed S; Church DL
    J Clin Microbiol; 2007 Feb; 45(2):294-8. PubMed ID: 17122002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya.
    Pitout JD; Revathi G; Chow BL; Kabera B; Kariuki S; Nordmann P; Poirel L
    Clin Microbiol Infect; 2008 Aug; 14(8):755-9. PubMed ID: 18727799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima.
    Kouda S; Ohara M; Onodera M; Fujiue Y; Sasaki M; Kohara T; Kashiyama S; Hayashida S; Harino T; Tsuji T; Itaha H; Gotoh N; Matsubara A; Usui T; Sugai M
    J Antimicrob Chemother; 2009 Jul; 64(1):46-51. PubMed ID: 19398456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan.
    Huang YT; Chang SC; Lauderdale TL; Yang AJ; Wang JT
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):211-6. PubMed ID: 17521840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes.
    Van der Bij AK; Van Mansfeld R; Peirano G; Goessens WH; Severin JA; Pitout JD; Willems R; Van Westreenen M
    Int J Antimicrob Agents; 2011 Jun; 37(6):513-8. PubMed ID: 21497065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity.
    Lagatolla C; Edalucci E; Dolzani L; Riccio ML; De Luca F; Medessi E; Rossolini GM; Tonin EA
    J Clin Microbiol; 2006 Jul; 44(7):2348-53. PubMed ID: 16825348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion.
    Samuelsen O; Toleman MA; Sundsfjord A; Rydberg J; Leegaard TM; Walder M; Lia A; Ranheim TE; Rajendra Y; Hermansen NO; Walsh TR; Giske CG
    Antimicrob Agents Chemother; 2010 Jan; 54(1):346-52. PubMed ID: 19884381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections.
    Tsakris A; Poulou A; Kristo I; Pittaras T; Spanakis N; Pournaras S; Markou F
    J Clin Microbiol; 2009 Nov; 47(11):3524-9. PubMed ID: 19776233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.
    Laupland KB; Parkins MD; Church DL; Gregson DB; Louie TJ; Conly JM; Elsayed S; Pitout JD
    J Infect Dis; 2005 Nov; 192(9):1606-12. PubMed ID: 16206075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.
    Crespo MP; Woodford N; Sinclair A; Kaufmann ME; Turton J; Glover J; Velez JD; Castañeda CR; Recalde M; Livermore DM
    J Clin Microbiol; 2004 Nov; 42(11):5094-101. PubMed ID: 15528701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-beta-lactamase in a hospital located in Rio de Janeiro, Brazil.
    Carvalho AP; Albano RM; de Oliveira DN; Cidade DA; Teixeira LM; Marques Ede A
    Microb Drug Resist; 2006; 12(2):103-8. PubMed ID: 16922625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea.
    Yoo JS; Yang JW; Kim HM; Byeon J; Kim HS; Yoo JI; Chung GT; Lee YS
    Int J Antimicrob Agents; 2012 Apr; 39(4):300-4. PubMed ID: 22325122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC(6')-Iae in Japan.
    Kitao T; Tada T; Tanaka M; Narahara K; Shimojima M; Shimada K; Miyoshi-Akiyama T; Kirikae T
    Int J Antimicrob Agents; 2012 Jun; 39(6):518-21. PubMed ID: 22483560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals.
    Glupczynski Y; Bogaerts P; Deplano A; Berhin C; Huang TD; Van Eldere J; Rodriguez-Villalobos H
    J Antimicrob Chemother; 2010 May; 65(5):866-71. PubMed ID: 20200037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing prevalence of imipenem-resistant Pseudomonas aeruginosa and molecular typing of metallo-beta-lactamase producers in a Korean hospital.
    Kim IS; Lee NY; Ki CS; Oh WS; Peck KR; Song JH
    Microb Drug Resist; 2005; 11(4):355-9. PubMed ID: 16359195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype.
    Pollini S; Fiscarelli E; Mugnaioli C; Di Pilato V; Ricciotti G; Neri AS; Rossolini GM
    Clin Microbiol Infect; 2011 Aug; 17(8):1272-5. PubMed ID: 21375657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.